Sun Rationalization Underway; To Shed Irish Facility
This article was originally published in Scrip
Executive Summary
India's top drug firm, Sun Pharmaceutical Industries, expects to divest its Irish site. This is probably among the first of such decisions as the company goes about complex rationalization efforts aimed at deriving synergy benefits from the Ranbaxy acquisition.